![Xavier Matias-Guiu Guia](/media/upload/cache/129949_a115x115.jpg)
Xavier Matias-Guiu Guia
Degree: PhD
973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/C-3039-2009
Groups
Publications
-
Irving, JA; Catasus, L; Gallardo, A; Bussaglia, E; Romero, M; Matias-Guiu, X; Prat, J
Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis
HUMAN PATHOLOGY 36 605-619. .
-
Dolcet, X; Llobet, D; Pallares, J; Matias-Guiu, X
NF-kB in development and progression of human cancer.
VIRCHOWS ARCHIV 446 475-482. .
-
Pallares, J; Bussaglia, E; Martinez-Guitarte, JL; Dolcet, X; Llobet, D; Rue, M; Sanchez-Verde, L; Palacios, J; Prat, J; Matias-Guiu, X
Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities.
Modern Pathology 18 719-727. .
-
Isidro, ML; Diaz, PI; Matias-Guiu, X; Cordido, F
Acromegaly due to a growth hormone-releasing hormone-secreting intracranial gangliocytoma
Journal Of Endocrinological Investigation 28 162-165. .
-
Pallares, J; Martinez-Guitarte, JL; Dolcet, X; Llobet, D; Rue, M; Palacios, J; Prat, J; Matias-Guiu, X
Abnormalities in the NF-kappaB family and related proteins in endometrial carcinoma.
JOURNAL OF PATHOLOGY 204 569-577. .
-
Vidal, D; Matias-Guiu, X; Alomar, A
Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma
CLINICAL AND EXPERIMENTAL DERMATOLOGY 29 518-525. .
-
Vidal, D; Matias-Guiu, X; Alomar, A
Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosis
BRITISH JOURNAL OF DERMATOLOGY 151 656-662. .
-
Toll, A; Gilaberte, M; Matias-Guiu, X; Camacho, L; Alomar, A; Gonzalez-Gay, MA; Pujol, RM
Kikuchi's disease (necrotizing lymphadenitis) with cutaneous involvement associated with subacute cutaneous lupus erythematosus
CLINICAL AND EXPERIMENTAL DERMATOLOGY 29 240-243. .
-
Moreno-Bueno, G; Hardisson, D; Prat, J; Matias-Guiu, J; Palacios, J
Re: Scholten et al. nuclear beta-catenin is a molecular feature of type I endometrial carcinoma. J Pathol 2003; 201 : 460-465
JOURNAL OF PATHOLOGY 202 511-512. .
-
Trovisco, V; de Castro, IV; Soares, P; Maximo, V; Silva, P; Magalhaes, J; Abrosimov, A; Guiu, XM; Sobrinho-Simoes, M
BRaF mutations are associated with some histological types of papillary thyroid carcinoma
JOURNAL OF PATHOLOGY 202 247-251. .
-
Valenzuela, N; Barnadas, MA; Matias-Guiu, X; Curell, R; de Andres, L; Alomar, A
Lethal perianal Buschke-Lowenstein tumor in a female patient with aIDS
Dermatology 208 349-350. .
-
Pallares, J; Perez-Ruiz, L; Ros, S; Panades, J; Pardo-Mindan, J; Lloreta, J; Matias-Guiu, X
Malignant peripheral nerve sheath tumor of the thyroid: a clinicopathological and ultrastructural study of one case.
ENDOCRINE PATHOLOGY 15 167-174. .
Projects
- Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
- EPH Receptor Signaling in Endometrial Cancer
- Ajuts per a la contractació de personal investigador novell (FI)
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
- EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
- Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
- DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
- Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
- VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU